Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC – Get Free Report) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 26,600 shares, a drop of 35.9% from the February 29th total of 41,500 shares. Based on an average trading volume of 163,500 shares, the days-to-cover ratio is presently 0.2 […]
StockNews.com upgraded shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) from a sell rating to a hold rating in a research note released on Thursday morning. Several other brokerages also recently commented on CYCC. Roth Mkm upped their price objective on shares of Cyclacel Pharmaceuticals from $16.00 to $21.00 and gave the company a buy […]
Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report released on Wednesday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other analysts have also recently weighed in on the stock. Roth Mkm raised their price target on shares of Cyclacel Pharmaceuticals from $16.00 […]
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.